Search

Your search keyword '"Nathaniel A. Chin"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Nathaniel A. Chin" Remove constraint Author: "Nathaniel A. Chin"
113 results on '"Nathaniel A. Chin"'

Search Results

1. Communicating Alzheimer's biomarker results to cognitively unimpaired research participants: Satisfaction, utility, and impact on research attitudes

2. Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status

3. The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults

4. The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research

5. Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort

6. The physician's Alzheimer's disease management guide: Early detection and diagnosis of cognitive impairment, Alzheimer's disease and related dementia

7. Anticipated reactions to learning Alzheimer’s disease biomarker results

8. Comparing emergency department use among individuals with varying levels of cognitive impairment

9. Sympathoexcitatory Responses to Isometric Handgrip Exercise Are Associated With White Matter Hyperintensities in Middle-Aged and Older Adults

10. Prescription Medications and Co-Morbidities in Late Middle-Age are Associated with Greater Cognitive Declines: Results from WRAP

11. Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers

12. Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know

13. Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values

14. Amyloid duration is associated with preclinical cognitive decline and tau PET

15. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum

16. The Wisconsin Alzheimer's Institute Dementia Diagnostic Clinic Network: A community of practice to improve dementia care

17. New insights into the genetic etiology of Alzheimer's disease and related dementias

18. Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results

19. Five-year changes in objectively measured cardiorespiratory fitness, physical activity, and sedentary time in mid-to-late adulthood

20. Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease

21. EFFECT OF METABOLIC SYNDROME RISK FACTORS ON PROCESSING SPEED AND EXECUTIVE FUNCTION IN THREE RACIALIZED GROUPS

22. Associations between Recall of Proper Names in Story Recall and CSF Amyloid and Tau in a Cognitively Unimpaired Sample

24. Diabetes is related to cognition but not plasma amyloid‐β 42/40 in an African American cohort

25. Amyloid duration and entorhinal tau interact to influence cognition in preclinical Alzheimer’s disease

26. Associations between semantic memory for proper names in story recall and CSF amyloid and tau in a cognitively unimpaired sample

27. Examining cerebrovascular burden across the cognitive continuum in older adults with and without evidence of amyloidosis

28. Poorer dexterity is associated with underlying Alzheimer’s disease brain pathology

29. Health behaviors and advanced planning in cognitively unimpaired older adults following amyloid PET disclosure: Preliminary findings from the Wisconsin Registry for Alzheimer’s Prevention

30. An examination of baseline plasma Aβ42/40 and intra‐individual cognitive variability (IICV) associations with longitudinal cognitive change in a Black Cohort: Data from the African Americans Fighting Alzheimer’s in Midlife (AA‐FAIM) study

31. Plasma Aβ42/40 and PET amyloid associations among late‐middle‐aged African Americans: Preliminary results from the AA‐FAIM study

32. Feasibility and reliability of telephone‐based cognitive assessment in middle‐aged and older adults in the Wisconsin Alzheimer’s Disease Research Center

33. Empirically derived 'discourse phenotypes' are associated with neuropsychological performance, cognitive status, and global atrophy: A latent profile analysis of connected speech measures

34. Social isolation and cognitive function in middle aged and older adults in the Wisconsin Alzheimer’s Disease Research Center: Implications for the pandemic

35. Bacteroides genus is associated with lower executive function in cognitively unimpaired participants

36. Trajectories of plasma Aβ42/40 among African Americans: Preliminary results from the African American Fighting Alzheimer’s in Midlife (AA‐FAIM) study

37. Participant education and preparedness in learning personal β‐amyloid PET results: Preliminary findings from the Wisconsin Registry for Alzheimer’s Prevention

38. Unexpected Findings from 8,205 Brain Magnetic Resonance Imaging Examinations of Research Volunteers ≥ 40 years old

39. Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences

40. Cigarette Smoking Status, Cigarette Exposure, and Duration of Abstinence Predicting Incident Dementia and Death: A Multistate Model Approach

41. Plasma pTau-217 in preclinical Alzheimer’s disease

43. What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis

44. The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research

45. Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society

46. Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample

47. Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing

48. Trajectory of clinical symptoms in relation to amyloid chronicity

49. Amyloid time: Quantifying the onset of abnormal biomarkers and cognitive impairment along the Alzheimer’s disease continuum

Catalog

Books, media, physical & digital resources